616455 Sigma-AldrichTGF-β1, Human, Recombinant, CHO Cell Line
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
Purity |
---|
≥97% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from a sterile filtered solution in 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Biological activity | ED₅₀ = 0.04-0.1 ng/ml |
Purity | ≥97% by SDS-PAGE |
Physicochemical Information | |
---|---|
Contaminants | Endotoxin: ≤1 EU/µg TGF-β1 |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
616455 | 0 |
Documentation
TGF-β1, Human, Recombinant, CHO Cell Line FDS
Titre |
---|
TGF-β1, Human, Recombinant, CHO Cell Line Certificats d'analyse
Titre | Numéro de lot |
---|---|
616455 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Shibuya, H., et al. 1996. Science 272, 1179. Bottlinger, E.P., et al. 1995. Proc. Natl. Acad. Sci. USA 93, 5877. Lomo, J., et al. 1995. J. Immunol. 154, 1634. Marushige, K., and Marushige, Y. 1995. Anticancer Res. 14, 2419. Yamazaki, M., et al. 1994. Am. J. Pathol. 144, 221. |